Type 2 Diabetes Mellitus Increases The Risk of Late-Onset Alzheimer's Disease: Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic animal model data with no new human clinical measurements.
PubMed 31569571 · doi:10.3390/brainsci9100262
What was done
This narrative review examined mechanistic pathways linking type 2 diabetes mellitus (T2DM) to an increased risk of late-onset Alzheimer's disease (LOAD). The authors reviewed five intersecting links (aging, metabolic factors such as AGE/RAGE interactions and insulin resistance, oxidative stress, inflammation, and vascular remodeling) and evaluated ultrastructural images of mural and glial cellular changes in female diabetic db/db mouse models.
What was found
The abstract reports no numerical findings, effect sizes, or quantitative data. It qualitatively describes ultrastructural remodeling of mural and glial cells in db/db mice and outlines how diabetes-associated microvascular neurovascular unit (NVU) and neuroglial remodeling correlate with impaired cerebral blood flow and neuronal vulnerability.
Why it matters
The paper synthesizes how microvascular and glial remodeling induced by metabolic dysfunction may mechanistically accelerate neurodegenerative processes underlying late-onset Alzheimer's disease.
Limits
The paper is a narrative review with bench/animal data (female db/db mice) and contains no primary human clinical data or statistical measurements. No sample sizes are reported in the abstract.
Cited by
- supports RAGE receptors on microglial cells respond to advanced glycation end products resulting from chronically elevated blood sugar.